No takes yet. Share an insight, caveat, or question.
Animal study demonstrates that activating bile acid receptor TGR5 curbs liver inflammation in mice, highlighting a promising therapeutic target for inflammatory liver diseases.
Wang et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: